Which has preferable valuation and earnings, PDEX or MDAI?

Pro-Dex has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $74.64M 2.81 $8.98M $3.62 18.14 Spectral AI $19.65M 2.59 -$7.57M -$0.35 N/A

Is PDEX or MDAI more profitable?

Pro-Dex has a net margin of 16.08% compared to Spectral AI's net margin of -69.27%. Pro-Dex's return on equity of 22.78% beat Spectral AI's return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 16.08% 22.78% 14.30% Spectral AI -69.27% N/A -78.56%

Does the media prefer PDEX or MDAI?

In the previous week, Spectral AI had 4 more articles in the media than Pro-Dex. MarketBeat recorded 6 mentions for Spectral AI and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.71 beat Spectral AI's score of 0.01 indicating that Pro-Dex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Spectral AI 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Is MDAI or CNXU more profitable?

Conexeu Sciences has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%. Company Net Margins Return on Equity Return on Assets Spectral AI -69.27% N/A -78.56% Conexeu Sciences N/A N/A N/A

Does the media refer more to MDAI or CNXU?

In the previous week, Spectral AI had 3 more articles in the media than Conexeu Sciences. MarketBeat recorded 6 mentions for Spectral AI and 3 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.82 beat Spectral AI's score of 0.01 indicating that Conexeu Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Conexeu Sciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate INGN or MDAI?

Spectral AI has a consensus price target of $4.00, indicating a potential upside of 150.00%. Given Spectral AI's stronger consensus rating and higher probable upside, analysts plainly believe Spectral AI is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Spectral AI 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Is INGN or MDAI more profitable?

Inogen has a net margin of -6.94% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Inogen's return on equity. Company Net Margins Return on Equity Return on Assets Inogen -6.94% -13.17% -8.36% Spectral AI -69.27% N/A -78.56%

Does the media favor INGN or MDAI?

In the previous week, Spectral AI had 5 more articles in the media than Inogen. MarketBeat recorded 6 mentions for Spectral AI and 1 mentions for Inogen. Spectral AI's average media sentiment score of 0.01 beat Inogen's score of -0.15 indicating that Spectral AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Spectral AI 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Is MDAI or OWLT more profitable?

Owlet has a net margin of -8.61% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Spectral AI -69.27% N/A -78.56% Owlet -8.61% -601.24% -15.96%

Does the media refer more to MDAI or OWLT?

In the previous week, Spectral AI had 2 more articles in the media than Owlet. MarketBeat recorded 6 mentions for Spectral AI and 4 mentions for Owlet. Owlet's average media sentiment score of 0.86 beat Spectral AI's score of 0.01 indicating that Owlet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Owlet 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MDAI or KRMD?

In the previous week, Spectral AI had 5 more articles in the media than KORU Medical Systems. MarketBeat recorded 6 mentions for Spectral AI and 1 mentions for KORU Medical Systems. Spectral AI's average media sentiment score of 0.01 beat KORU Medical Systems' score of 0.00 indicating that Spectral AI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral KORU Medical Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Spectral AI (MDAI) Competitors

$1.60 +0.03 (+1.91%)

As of 08/21/2026 04:00 PM Eastern

Compare

MDAI vs. PDEX, CNXU, INGN, OWLT, and KRMD

Should you buy Spectral AI stock or one of its competitors? Spectral AI's main competitors and comparable companies include Pro-Dex (PDEX), Conexeu Sciences (CNXU), Inogen (INGN), Owlet (OWLT), and KORU Medical Systems (KRMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Spectral AI compare to Pro-Dex?

Pro-Dex (NASDAQ:PDEX) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

Pro-Dex presently has a consensus target price of $70.00, indicating a potential upside of 6.59%. Spectral AI has a consensus target price of $4.00, indicating a potential upside of 150.00%. Given Spectral AI's higher probable upside, analysts plainly believe Spectral AI is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Pro-Dex has a net margin of 16.08% compared to Spectral AI's net margin of -69.27%. Pro-Dex's return on equity of 22.78% beat Spectral AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	16.08%	22.78%	14.30%
Spectral AI	-69.27%	N/A	-78.56%

15.3% of Pro-Dex shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 45.9% of Pro-Dex shares are held by company insiders. Comparatively, 13.7% of Spectral AI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Pro-Dex has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$74.64M	2.81	$8.98M	$3.62	18.14
Spectral AI	$19.65M	2.59	-$7.57M	-$0.35	N/A

Pro-Dex has a beta of 0.02, indicating that its stock price is 98% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

In the previous week, Spectral AI had 4 more articles in the media than Pro-Dex. MarketBeat recorded 6 mentions for Spectral AI and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.71 beat Spectral AI's score of 0.01 indicating that Pro-Dex is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pro-Dex	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spectral AI	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Pro-Dex beats Spectral AI on 11 of the 16 factors compared between the two stocks.

How does Spectral AI compare to Conexeu Sciences?

Spectral AI (NASDAQ:MDAI) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Conexeu Sciences has lower revenue, but higher earnings than Spectral AI. Conexeu Sciences is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.59	-$7.57M	-$0.35	N/A
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.11	N/A

Conexeu Sciences has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
Conexeu Sciences	N/A	N/A	N/A

In the previous week, Spectral AI had 3 more articles in the media than Conexeu Sciences. MarketBeat recorded 6 mentions for Spectral AI and 3 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.82 beat Spectral AI's score of 0.01 indicating that Conexeu Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Conexeu Sciences	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

67.1% of Spectral AI shares are held by institutional investors. 13.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Spectral AI presently has a consensus target price of $4.00, suggesting a potential upside of 150.00%. Conexeu Sciences has a consensus target price of $20.00, suggesting a potential upside of 124.97%. Given Spectral AI's stronger consensus rating and higher probable upside, research analysts clearly believe Spectral AI is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Spectral AI beats Conexeu Sciences on 8 of the 13 factors compared between the two stocks.

How does Spectral AI compare to Inogen?

Inogen (NASDAQ:INGN) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

Inogen has a beta of 1.55, indicating that its share price is 55% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

Spectral AI has a consensus price target of $4.00, indicating a potential upside of 150.00%. Given Spectral AI's stronger consensus rating and higher probable upside, analysts plainly believe Spectral AI is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Inogen has a net margin of -6.94% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-6.94%	-13.17%	-8.36%
Spectral AI	-69.27%	N/A	-78.56%

89.9% of Inogen shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 2.5% of Inogen shares are held by insiders. Comparatively, 13.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Spectral AI had 5 more articles in the media than Inogen. MarketBeat recorded 6 mentions for Spectral AI and 1 mentions for Inogen. Spectral AI's average media sentiment score of 0.01 beat Inogen's score of -0.15 indicating that Spectral AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inogen	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Spectral AI	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Spectral AI has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$348.67M	0.43	-$22.75M	-$0.90	N/A
Spectral AI	$19.65M	2.59	-$7.57M	-$0.35	N/A

Summary

Spectral AI beats Inogen on 11 of the 16 factors compared between the two stocks.

How does Spectral AI compare to Owlet?

Spectral AI (NASDAQ:MDAI) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Spectral AI has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.59	-$7.57M	-$0.35	N/A
Owlet	$105.70M	1.45	-$39.68M	-$0.75	N/A

Owlet has a net margin of -8.61% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
Owlet	-8.61%	-601.24%	-15.96%

Spectral AI has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market. Comparatively, Owlet has a beta of 1.85, indicating that its stock price is 85% more volatile than the broader market.

Spectral AI presently has a consensus price target of $4.00, indicating a potential upside of 150.00%. Owlet has a consensus price target of $15.00, indicating a potential upside of 186.81%. Given Owlet's higher probable upside, analysts plainly believe Owlet is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Spectral AI had 2 more articles in the media than Owlet. MarketBeat recorded 6 mentions for Spectral AI and 4 mentions for Owlet. Owlet's average media sentiment score of 0.86 beat Spectral AI's score of 0.01 indicating that Owlet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Owlet	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 13.7% of Spectral AI shares are owned by company insiders. Comparatively, 36.2% of Owlet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Owlet beats Spectral AI on 9 of the 17 factors compared between the two stocks.

How does Spectral AI compare to KORU Medical Systems?

Spectral AI (NASDAQ:MDAI) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

In the previous week, Spectral AI had 5 more articles in the media than KORU Medical Systems. MarketBeat recorded 6 mentions for Spectral AI and 1 mentions for KORU Medical Systems. Spectral AI's average media sentiment score of 0.01 beat KORU Medical Systems' score of 0.00 indicating that Spectral AI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
KORU Medical Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Spectral AI has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market.

KORU Medical Systems has higher revenue and earnings than Spectral AI. KORU Medical Systems is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.59	-$7.57M	-$0.35	N/A
KORU Medical Systems	$41.13M	3.58	-$2.64M	-$0.04	N/A

67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 13.7% of Spectral AI shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Spectral AI currently has a consensus target price of $4.00, indicating a potential upside of 150.00%. KORU Medical Systems has a consensus target price of $7.00, indicating a potential upside of 118.07%. Given Spectral AI's stronger consensus rating and higher probable upside, analysts clearly believe Spectral AI is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

KORU Medical Systems has a net margin of -4.03% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
KORU Medical Systems	-4.03%	-10.63%	-6.51%

Summary

Spectral AI beats KORU Medical Systems on 9 of the 17 factors compared between the two stocks.

Get Spectral AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDAI vs. The Competition

Export

Metric	Spectral AI	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$50.92M	$6.02B	$7.37B	$12.85B
Dividend Yield	N/A	1.75%	2.54%	11.08%
P/E Ratio	-4.57	26.67	272.88	24.24
Price / Sales	2.59	45.38	618.96	99.76
Price / Cash	N/A	33.24	78.62	53.99
Price / Book	-4.21	6.23	13.05	6.20
Net Income	-$7.57M	$150.07M	$3.47B	$348.59M
7 Day Performance	-4.76%	0.69%	2.09%	0.08%
1 Month Performance	-2.44%	8.91%	6.64%	3.88%
1 Year Performance	-23.44%	8.07%	25.02%	16.98%

Spectral AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDAI Spectral AI	2.9957 of 5 stars	$1.60 +1.9%	$4.00 +150.0%	-23.4%	$50.92M	$19.65M	N/A	83	News Coverage Analyst Downgrade Analyst Revision
PDEX Pro-Dex	1.5467 of 5 stars	$66.72 +0.7%	$70.00 +4.9%	+42.7%	$211.54M	$66.59M	18.43	140	News Coverage
CNXU Conexeu Sciences	3.8109 of 5 stars	$7.44 +2.3%	$20.00 +168.8%	N/A	$194.53M	N/A	N/A	4
INGN Inogen	1.1445 of 5 stars	$5.90 -2.0%	N/A	-27.6%	$159.76M	$348.67M	N/A	1,030
OWLT Owlet	3.2253 of 5 stars	$5.46 +0.7%	$15.00 +174.8%	-30.5%	$157.53M	$105.70M	N/A	106	News Coverage High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MDAI) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Spectral AI (MDAI) Competitors